• Je něco špatně v tomto záznamu ?

Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action

R. Ceña-Diez, E. Vacas-Córdoba, P. García-Broncano, FJ. de la Mata, R. Gómez, M. Maly, MÁ. Muñoz-Fernández,

. 2016 ; 11 (-) : 2147-62. [pub] 20160519

Jazyk angličtina Země Nový Zéland

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013790

Topical microbicides to stop sexually transmitted diseases, such as herpes simplex virus type 2 (HSV-2), are urgently needed. The emerging field of nanotechnology offers novel suitable tools for addressing this challenge. Our objective was to study, in vitro and in vivo, antiherpetic effect and antiviral mechanisms of several polyanionic carbosilane dendrimers with anti-HIV-1 activity to establish new potential microbicide candidates against sexually transmitted diseases. Plaque reduction assay on Vero cells proved that G2-S16, G1-S4, and G3-S16 are the dendrimers with the highest inhibitory response against HSV-2 infection. We also demonstrated that our dendrimers inhibit viral infection at the first steps of HSV-2 lifecycle: binding/entry-mediated events. G1-S4 and G3-S16 bind directly on the HSV-2, inactivating it, whereas G2-S16 adheres to host cell-surface proteins. Molecular modeling showed that G1-S4 binds better at binding sites on gB surface than G2-S16. Significantly better binding properties of G1-S4 than G2-S16 were found in an important position for affecting transition of gB trimer from G1-S4 prefusion to final postfusion state and in several positions where G1-S4 could interfere with gB/gH-gL interaction. We demonstrated that these polyanionic carbosilan dendrimers have a synergistic activity with acyclovir and tenofovir against HSV-2, in vitro. Topical vaginal or rectal administration of G1-S4 or G2-S16 prevents HSV-2 transmission in BALB/c mice in values close to 100%. This research represents the first demonstration that transmission of HSV-2 can be blocked by vaginal/rectal application of G1-S4 or G2-S16, providing a step forward to prevent HSV-2 transmission in humans.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013790
003      
CZ-PrNML
005      
20170427110055.0
007      
ta
008      
170413s2016 nz f 000 0|eng||
009      
AR
024    7_
$a 10.2147/IJN.S95301 $2 doi
035    __
$a (PubMed)27274240
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a nz
100    1_
$a Ceña-Diez, Rafael $u Molecular Immunobiology Laboratory, General Universitary Hospital Gregorio Marañon, Health Research Institute Gregorio Marañon, Spanish HIV HGM BioBank, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.
245    10
$a Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action / $c R. Ceña-Diez, E. Vacas-Córdoba, P. García-Broncano, FJ. de la Mata, R. Gómez, M. Maly, MÁ. Muñoz-Fernández,
520    9_
$a Topical microbicides to stop sexually transmitted diseases, such as herpes simplex virus type 2 (HSV-2), are urgently needed. The emerging field of nanotechnology offers novel suitable tools for addressing this challenge. Our objective was to study, in vitro and in vivo, antiherpetic effect and antiviral mechanisms of several polyanionic carbosilane dendrimers with anti-HIV-1 activity to establish new potential microbicide candidates against sexually transmitted diseases. Plaque reduction assay on Vero cells proved that G2-S16, G1-S4, and G3-S16 are the dendrimers with the highest inhibitory response against HSV-2 infection. We also demonstrated that our dendrimers inhibit viral infection at the first steps of HSV-2 lifecycle: binding/entry-mediated events. G1-S4 and G3-S16 bind directly on the HSV-2, inactivating it, whereas G2-S16 adheres to host cell-surface proteins. Molecular modeling showed that G1-S4 binds better at binding sites on gB surface than G2-S16. Significantly better binding properties of G1-S4 than G2-S16 were found in an important position for affecting transition of gB trimer from G1-S4 prefusion to final postfusion state and in several positions where G1-S4 could interfere with gB/gH-gL interaction. We demonstrated that these polyanionic carbosilan dendrimers have a synergistic activity with acyclovir and tenofovir against HSV-2, in vitro. Topical vaginal or rectal administration of G1-S4 or G2-S16 prevents HSV-2 transmission in BALB/c mice in values close to 100%. This research represents the first demonstration that transmission of HSV-2 can be blocked by vaginal/rectal application of G1-S4 or G2-S16, providing a step forward to prevent HSV-2 transmission in humans.
650    _2
$a acyklovir $x farmakologie $7 D000212
650    _2
$a aplikace rektální $7 D000285
650    _2
$a zvířata $7 D000818
650    _2
$a antiinfekční látky $x farmakologie $7 D000890
650    _2
$a antivirové látky $x farmakologie $7 D000998
650    _2
$a Cercopithecus aethiops $7 D002522
650    _2
$a dendrimery $x chemie $7 D050091
650    _2
$a epitelové buňky $x účinky léků $x virologie $7 D004847
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a herpes simplex $7 D006561
650    _2
$a lidský herpesvirus 2 $x účinky léků $7 D018258
650    _2
$a lidé $7 D006801
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a molekulární modely $7 D008958
650    _2
$a polymery $x chemie $7 D011108
650    _2
$a rektum $x účinky léků $x virologie $7 D012007
650    _2
$a silany $x chemie $7 D012821
650    _2
$a tenofovir $x farmakologie $7 D000068698
650    _2
$a vagina $x účinky léků $x virologie $7 D014621
650    _2
$a Vero buňky $7 D014709
650    _2
$a virové proteiny $x metabolismus $7 D014764
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vacas-Córdoba, Enrique $u Molecular Immunobiology Laboratory, General Universitary Hospital Gregorio Marañon, Health Research Institute Gregorio Marañon, Spanish HIV HGM BioBank, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.
700    1_
$a García-Broncano, Pilar $u Molecular Immunobiology Laboratory, General Universitary Hospital Gregorio Marañon, Health Research Institute Gregorio Marañon, Spanish HIV HGM BioBank, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain; Viral and Immune Infection Unit Center, Institute of Health Carlos III, Majadahonda Campus, Molecular Immunobiology Laboratory, General Universitary Hospital Gregorio Marañon, Madrid, Spain.
700    1_
$a de la Mata, F J $u Organic and Inorganic Chemistry Department, Alcala University, University Campus Alcala de Heneras, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.
700    1_
$a Gómez, Rafael $u Organic and Inorganic Chemistry Department, Alcala University, University Campus Alcala de Heneras, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.
700    1_
$a Maly, Marek $u Faculty of Science, J.E. Purkinje University, Ústí nad Labem, Czech Republic.
700    1_
$a Muñoz-Fernández, M Ángeles $u Molecular Immunobiology Laboratory, General Universitary Hospital Gregorio Marañon, Health Research Institute Gregorio Marañon, Spanish HIV HGM BioBank, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.
773    0_
$w MED00176143 $t International journal of nanomedicine $x 1178-2013 $g Roč. 11, č. - (2016), s. 2147-62
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27274240 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170427110415 $b ABA008
999    __
$a ok $b bmc $g 1200255 $s 974568
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 11 $c - $d 2147-62 $e 20160519 $i 1178-2013 $m International journal of nanomedicine $n Int J Nanomedicine $x MED00176143
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...